Citius Pharmaceuticals, Inc. CTXR
Citius Pharmaceuticals, Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating margin | — | — | — | -37017.8% | -26146.5% | -19678.5% | -17331.5% | -18385.5% | -19972.6% | — |
| Net margin | — | — | — | -37378.5% | -25616.0% | -19497.9% | -17291.3% | -16715.5% | -20769.9% | — |
| FCF margin | — | — | — | — | -26952.6% | -18813.9% | — | — | -15946.7% | — |
| Return on assets | — | — | -31.4% | -29.5% | -16.2% | -40.1% | -42.4% | -40.4% | -42.5% | -37.8% |
| Return on equity | — | — | -35.6% | -32.5% | -17.4% | -52.1% | -57.3% | -40.9% | -47.3% | -49.5% |
| Current ratio | 0.62 | 0.40 | 5.95 | 9.84 | 18.28 | 3.41 | 1.72 | 3.16 | 1.39 | 0.17 |
Computed from company filings · US · as of 2025-09-30. Facts plus Stocktoria's own computed scores — not investment advice.